EUVIMEDEUVIMED entdecken
Crossref

Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories

Sahlawati Mustakim, Jacinta Santhanam iD, Wan Nur Athirah Muhammad Ghazali iD, Murnihayati Hassan iD, Tzar Mohd Nizam, Syaziah Ibrahim, Marlinda Mohd Ali, Rayuwani Mohamad Kamal, Hafzan Baharim, Aniz Suriani Mohd Ali, Nor Izzah Mazan, Rinni Damayanti Samsuddin und 25 weitere

Medical Mycology · 2025

DOI: 10.1093/mmy/myaf056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Sahlawati Mustakim und 36 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Hospital Sungai Buloh, Sungai Buloh, Malaysia. Hauptthemen laut MEDLINE: Mycoses, Fungi, Laboratories. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections affect 2% of Malaysia’s population, yet little is known about mycology laboratory practices in the country. This study surveyed 48 medical institutions, including 14 state hospitals, 26 major specialist hospitals, 4 minor specialist hospitals, 3 university hospitals, and 1 reference laboratory, to assess current practices and identify areas for improvement. Nearly all hospitals performed germ tube testing for Candida albicans (87.5%, 42/48). Yeast identification was conducted using API® (52%, 25/48) or VITEK® (52%, 25/48), with two institutions employing both methods. Advanced methods like matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) were used in only 39.6% (19/48) of institutions, while PCR and DNA sequencing (6.3%, 3/48 each) were limited to university and reference labs. Mould identification primarily relied on the tease mount method (91.7%, 44/48), indicating widespread capability for morphological identification. Antifungal susceptibility testing for yeast was available in all hospitals except minor specialist hospitals, using VITEK® (35.4%, 17/48), Sensititre® (20.8%, 10/48), or Etest® (8.3%, 4/48). Serology testing focused on opportunistic mycoses, particularly Cryptococcus spp. (50.0%, 24/48), while testing for endemic pathogens like Histoplasma was rare (2.1%, 1/48). Aspergillosis testing was limited to galactomannan enzyme immunoassay and lateral flow assay (6.3%, 3/48 each), and no institutions performed (1,3)-beta-d-glucan testing. While advanced diagnostics were available in state and major hospitals, minor specialist hospitals lacked access. These findings highlight the urgent need to enhance laboratory infrastructure, expand access to advanced diagnostics like MALDI-TOF, and train personnel to improve fungal infection management in Malaysia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MycosesFungiLaboratoriesMalaysiaHumansSurveys and QuestionnairesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Malaysiacapacitydiagnosticlaboratorymycology

Autor:innen und Institutionen

  • Pathology Department, Hospital Sungai Buloh, Sungai Buloh, Malaysia.
  • Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Infectious Disease Research Centre, Institute for Medical Research, Setia Alam, Malaysia.
  • Department of Diagnostic Laboratory Services, Hospital Canselor Tuanku Muhriz, Kuala Lumpur, Malaysia.
  • Pathology Department, Hospital Melaka, Melaka, Malaysia.
  • Pathology Department, Hospital Tuanku Jaafar, Seremban, Malaysia.

ORCID-Profile: Jacinta Santhanam, Wan Nur Athirah Muhammad Ghazali, Murnihayati Hassan

Zitieren

APA

Mustakim, S., Santhanam, J., Muhammad Ghazali, W. N. A., Hassan, M., Mohd Nizam, T., Ibrahim, S., Mohd Ali, M., Mohamad Kamal, R., Baharim, H., Mohd Ali, A. S., Mazan, N. I., Samsuddin, R. D., Mohd Zaili, M. Z., Abdul Rahman, N., Syed Omar, S. S., Zawawi, R. D., Tan, R., Mokhtar, N. A., Rozik, A., …, & Chua, W. C. (2025). Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories. Medical Mycology. https://doi.org/10.1093/mmy/myaf056

Vancouver

Mustakim S, Santhanam J, Muhammad Ghazali WNA, Hassan M, Mohd Nizam T, Ibrahim S, et al. Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories. Medical Mycology. 2025. doi:10.1093/mmy/myaf056

BibTeX
@article{Mustakim2025,
  author = {Mustakim, Sahlawati and Santhanam, Jacinta and Muhammad Ghazali, Wan Nur Athirah and Hassan, Murnihayati and Mohd Nizam, Tzar and Ibrahim, Syaziah and Mohd Ali, Marlinda and Mohamad Kamal, Rayuwani and Baharim, Hafzan and Mohd Ali, Aniz Suriani and Mazan, Nor Izzah and Samsuddin, Rinni Damayanti and Mohd Zaili, Mohd Zaki and Abdul Rahman, Noorhayati and Syed Omar, Sharifah Saidah and Zawawi, Ruzanna Dayanna and Tan, Ruixin and Mokhtar, Nor Akmal and Rozik, Amalina and Che Hussin, Nurzam Suhaila and Umur Adli, Nurulhuda and Zam, Zarifah and Md Radzi, Nor Anisa and Muhammad, Susilahwati and Zainol, Noor Hasliza and Sidek, Nurul Azira and Hussin, Azura and Ahmad Ghazali, Wan Azlirull Aini and Yusoff, Yuhin Karina and Hamzah, Siti Hawa and Ahmad Tajudin, Edahayati and Rosli, Roshalina and Velayuthan, Rukumani Devi and Othman, Norlela and Abd Razak, Dayangku Seritul Akmar and Nasran, Nasrina and Chua, Wei Chuan},
  title = {Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories},
  journal = {Medical Mycology},
  year = {2025},
  doi = {10.1093/mmy/myaf056}
}
Kostenlos starten →